| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/19/2007 | WO2007044688A1 Nucleic acids encoding modified cytochrome p450 enzymes and methods of use thereof |
| 04/19/2007 | WO2007044610A2 Virus-like particles and methods of use |
| 04/19/2007 | WO2007044406A2 Methods for stimulating an immune response using bacterial antigen delivery system |
| 04/19/2007 | WO2007044362A2 Allele-specific rna interference |
| 04/19/2007 | WO2007044043A2 Transgenic plants with enhanced agronomic traits |
| 04/19/2007 | WO2007044024A2 Recombinant influenza vectors with tandem transcription units |
| 04/19/2007 | WO2007043784A1 Rna aptamers and the uses thereof |
| 04/19/2007 | WO2007043769A1 Hyperthermophilic dna polymerase and methods of preparation thereof |
| 04/19/2007 | WO2007043715A1 Rna-binding peptide |
| 04/19/2007 | WO2007043635A1 Preventive/remedy for cancer |
| 04/19/2007 | WO2007043629A1 Method of inhibiting angiogenesis by using ephrin b2 |
| 04/19/2007 | WO2007043623A1 Novel transporter protein in mammal and utilization of the same |
| 04/19/2007 | WO2007043589A1 Animal model of schizophrenia |
| 04/19/2007 | WO2007043582A1 Method for determination of sars virus nucleocapsid protein, reagent kit for the determination, test device, monoclonal antibody directed against sars virus nucleocapsid protein, and hybridoma capable of producing the monoclonal antibody |
| 04/19/2007 | WO2007043531A1 Genetic marker for use in diagnosis of sensitivity to anti-tumor agent or concurrent chemoradiation therapy, and use thereof |
| 04/19/2007 | WO2007043523A1 Transfection device |
| 04/19/2007 | WO2007043494A1 Method of collecting dna from biological sample |
| 04/19/2007 | WO2007043418A1 Method for prediction of postoperative prognosis for patient with pulmonary adenocarcinoma, and composition for use in the prediction |
| 04/19/2007 | WO2007043404A1 Saspase knockout animal |
| 04/19/2007 | WO2007043346A1 Method for producing nuclear-transplanted egg |
| 04/19/2007 | WO2007043330A1 Process for producing recombinant protein |
| 04/19/2007 | WO2007043327A1 Novel bacillus subtilis mutant strain |
| 04/19/2007 | WO2007043295A1 Method of identifying compounds inhibiting ddx39 |
| 04/19/2007 | WO2007043287A1 TRANSCRIPTIONAL REGULATION OF HIGH AFFINITY IgE RECEPTOR Ϝ-CHAIN |
| 04/19/2007 | WO2007043253A1 Yeast and method of producing l-lactic acid |
| 04/19/2007 | WO2007043200A1 T cell differentiation controller |
| 04/19/2007 | WO2007043049A1 Compositions for silencing the expression of vdac1 and uses thereof |
| 04/19/2007 | WO2007042899A2 Human microrna targets in hiv genome and a method of identification thereof |
| 04/19/2007 | WO2007042827A2 Treatment and diagnosis of obligate intracellular pathogens |
| 04/19/2007 | WO2007042792A1 Gpr 146 receptor |
| 04/19/2007 | WO2007042771A1 Three hybrid screening assay using reverse transfected mammalian cell arrays |
| 04/19/2007 | WO2007042554A2 Methods and compositions for treating immune disorders |
| 04/19/2007 | WO2007042510A2 Process for the production of arachidonic acid and/or eicosapentaenoic acid |
| 04/19/2007 | WO2007042494A2 Microbiological production of 3-hydroxypropionic acid |
| 04/19/2007 | WO2007042444A1 New esterases and their use for processes for kinetic resolution of butinolesters |
| 04/19/2007 | WO2007042326A2 Neisseria meningitidis antigens |
| 04/19/2007 | WO2007042304A1 Astaxanthine biosynthesis in eukaryotes |
| 04/19/2007 | WO2007042289A2 Nanobodies™ and polypeptides against egfr and igf-ir |
| 04/19/2007 | WO2007041964A1 The use of long half-life human recombinant soluble tumor necrosis factor alpha receptor in preparing the medicine which can prevent hepatic failure |
| 04/19/2007 | WO2007041869A1 Reconstructed living adipose tissue |
| 04/19/2007 | WO2007041861A1 Chimeric antigen containing hepatitis c virus polypeptide and fc fragment for eliciting an immune response |
| 04/19/2007 | WO2007041846A1 Ste11p/ste50p related yeast two-hybrid and one-hybrid systems |
| 04/19/2007 | WO2007024535A3 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders |
| 04/19/2007 | WO2007024535A2 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders |
| 04/19/2007 | WO2007023190A3 Genes involved in asymmetric cell division |
| 04/19/2007 | WO2007014992A3 Antibodies directed against an ldl receptor |
| 04/19/2007 | WO2007010401A3 Glycosylated il-7, preparation and uses |
| 04/19/2007 | WO2007009233A3 Peptide-based cytokine vaccines in the treatment of autoimmune and inflammatory diseases |
| 04/19/2007 | WO2007001684A9 Inhibiting dna polymerase beta to enhance efficacy of anticancer agents |
| 04/19/2007 | WO2007000318A3 T cell lime-based packaging cell line for the production of retroviruses by enriching of cd3 expressing cells |
| 04/19/2007 | WO2006130580A3 Mutant il-10 |
| 04/19/2007 | WO2006121848A3 Method for the isolation of spiroplasma in mammals |
| 04/19/2007 | WO2006117381A3 Transgenic expression cartridges for expressing nucleic acids in the flower tissue of plants |
| 04/19/2007 | WO2006116541A3 Tat-002 and methods of assessing and treating cancer |
| 04/19/2007 | WO2006110309A9 Transgenic mice expressing a unique b cell population and methods of use |
| 04/19/2007 | WO2006093661A3 A method of truncating both ends of a large piece of dna |
| 04/19/2007 | WO2006091673A3 Crystal structure of tak1-tab1 |
| 04/19/2007 | WO2006078279A3 Sequential delivery of immunogenic molecules via adenovirus and adeno-associated virus-mediated administrations |
| 04/19/2007 | WO2006077112A3 Sirna molecules for treatment of blood vessels |
| 04/19/2007 | WO2006075039A3 Method for the in vitro diagnosis of familial hypercholesterolemia, comprising the detection of gene rearrangements |
| 04/19/2007 | WO2006066158A3 Rnai modulation of mll-af4 and uses thereof |
| 04/19/2007 | WO2006055697A3 Cancer immunotherapy incorporating p53 |
| 04/19/2007 | WO2006053155A3 Gp202: methods and compositions for treating cancer |
| 04/19/2007 | WO2006052731A3 Molecular indicators of breast cancer prognosis and prediction of treatment response |
| 04/19/2007 | WO2006047536A3 Methods and kits for detecting mutations |
| 04/19/2007 | WO2006031371A3 A method for producing non-human transgenic primates |
| 04/19/2007 | WO2005116237A3 Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for crystal structure determination |
| 04/19/2007 | WO2005085458A3 Polyacetal-peptide mediated transfection |
| 04/19/2007 | WO2005056802A3 Materials and methods relating to cell cycle control |
| 04/19/2007 | WO2005042747A3 Plant isoflavonoid hydroxylases and methods of use thereof |
| 04/19/2007 | WO2005035712A3 Methods and compositions for infectious cdna of sars coronavirus |
| 04/19/2007 | WO2004069849A8 Bead emulsion nucleic acid amplification |
| 04/19/2007 | WO2003002065A3 Hcv e1e2 vaccine compositions |
| 04/19/2007 | WO2002066614A3 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 04/19/2007 | US20070089211 High Artemisinin yielding plant genotype 'CIM-Arogya' |
| 04/19/2007 | US20070089203 Stress-responsiveness promoters suitable for directing gene expression in plant cells or plants; ryegrass |
| 04/19/2007 | US20070089202 Use of untranslated region of osmotin gene to enhance transgene expression in plants |
| 04/19/2007 | US20070089201 Plant production of immunoglobulins with reduced fucosylation |
| 04/19/2007 | US20070089200 Manipulating the expression of reversibly glycosylated polypeptide (RGP) in plants |
| 04/19/2007 | US20070089199 Plant cells; transfected with a recombinant nucleic acid molecule encoding a polyketide synthase (PKS) system for the production of polyunsaturated fatty acids (PUFAs) and a phosphopantetheine transferase |
| 04/19/2007 | US20070089198 Methods for Splicing Plant Genes |
| 04/19/2007 | US20070089197 Papaya ringspot virus genes |
| 04/19/2007 | US20070089196 Recombinant DNA constructs and methods for controlling gene expression |
| 04/19/2007 | US20070089185 Recombinant DNA constructs and methods for controlling gene expression |
| 04/19/2007 | US20070089184 Recombinant DNA constructs and methods for controlling gene expression |
| 04/19/2007 | US20070089183 Size and/or growth engineering by modulation of the interaction between calmodulin, and brassinosteroid biosynthetic enzymes and orthologs therof |
| 04/19/2007 | US20070089182 Regeneration |
| 04/19/2007 | US20070089181 Canola line 45H25 |
| 04/19/2007 | US20070089180 Transcription factors of cereals |
| 04/19/2007 | US20070089178 Modified Organs and Cells for Xenotransplantation |
| 04/19/2007 | US20070089176 Cytokine involved in epithelial-mesenchymal transition |
| 04/19/2007 | US20070089175 Mating a transgenic mouse whose genome encodes mouse perlecan, a large multidomain proteoglycan that binds and cross-links extracellular matrix (ECM) components and cell surface molecules, domains, with a second transgenic mouse whose genome encodes the human C terminal of A beta precursor protein |
| 04/19/2007 | US20070088510 Method and system for faster and more sensitive homology searching |
| 04/19/2007 | US20070088156 Recombinant viral-based malaria vaccines |
| 04/19/2007 | US20070088155 siRNA targeting tumor necrosis factor superfamily member 1A |
| 04/19/2007 | US20070088154 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response; specific gene silencing |
| 04/19/2007 | US20070088153 siRNA targeting BCL2L1 |
| 04/19/2007 | US20070088152 siRNA targeting KRAS |
| 04/19/2007 | US20070088151 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/19/2007 | US20070087991 Pluripotential stem cells |